Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 15
- Q3 2023, +3 vs. previous quarter
- 13F value
- $74.5K
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding BXRX, Q3 2023
No superinvestor reported holding BXRX at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by Baudax Bio, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Henwood GeraldinePresident and CEO | PPurchase | +1.20K | $2.55 | +$3.06K | +97.8%2.43K after | |
| Sep 23, 2021 (view filing) | Sep 22 | 1 day | Henwood GeraldinePresident and CEO | PPurchase | +8.20K | $0.59 | +$4.84K | +2.3%364.5K after | |
| Aug 31, 2021 (view filing) | Aug 31 | Same day | Churchill Winston JDirector | PPurchase | +100.0K | $0.63 | +$63.0K | +63.6%257.2K after | |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Casten Richard SChief Financial Officer | PPurchase | +50.0K | $0.51 | +$25.5K | +33.3%200.0K after |
Top 10 13F holders, Q3 2023
The largest institutional positions in Baudax Bio, Inc. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 48,300 | $17.9K | 0.00% | +23,400+94.0% | Added |
| Geode Capital Management, LLC | 45,363 | $16.8K | 0.00% | +45,363 | New |
| Virtu Financial LLC | 41,888 | $16.0K | 0.00% | +41,888 | New |
| XTX Topco Ltd | 23,426 | $8.67K | 0.00% | +23,426 | New |
| State Street Corp | 11,602 | $4.29K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,834 | $4.01K | 0.00% | +276+2.6% | Added |
| Susquehanna International Group, LLP | 10,699 | $3.96K | 0.00% | +10,699 | New |
| UBS Group AG | 6,844 | $2.53K | 0.00% | −2,812−29.1% | Reduced |
| BlackRock Inc. | 797 | $295 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 53 | $20 | 0.00% | +9+20.5% | Added |